Please login to the form below

Not currently logged in
Email:
Password:

CRO

This page shows the latest CRO news and features for those working in and with pharma, biotech and healthcare.

New industry standards group launched

New industry standards group launched

New industry standards group launched. Align Clinical CRO will improve clinical trial collaboration. ... Align Clinical CRO represents an important industry collaboration to improve the trial processes and how the industry works together to accelerate

Latest news

  • ICON boosts leadership teams ICON boosts leadership teams

    He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group. ... Carroll has over 20 years of CRO and pharmaceutical

  • Gilead's ulcerative colitis antibody flunks trial Gilead's ulcerative colitis antibody flunks trial

    fibrosis. In the summer it was reported that Gilead and contract research organisation (CRO) partner Quintiles were struggling to recruit patients into its phase II Crohn's disease trial.

  • Takeda signs strategic-level outsourcing deal with PRA Takeda signs strategic-level outsourcing deal with PRA

    pharmacovigilance and other operational support - with 300 of the Japanese company's R&D staff set to transfer to the contract research organisation (CRO). ... level and is described by the CRO's chief executive Colin Shannon as "the first of its kind in

  • EMA suspends generic drugs on data integrity concerns EMA suspends generic drugs on data integrity concerns

    The EU regulator has taken the step for a host of generics that rely on bioequivalence studies conducted at an Indian contract research organisation (CRO) - Bangalore-based Semler Research Centre Pvt

  • EU proposes reforms to make first-in-human trials safer EU proposes reforms to make first-in-human trials safer

    A subsequent inquiry by the French government put contract research organisation (CRO) Biotrial and pharmaceutical sponsor Bial at fault for the failings in the study and led to calls for tightened

More from news
Approximately 39 fully matching, plus 83 partially matching documents found.

Latest Intelligence

  • Real patient voices Real patient voices

    The #Human behind every number project

  • Deal Watch February 2017 Deal Watch February 2017

    It is apparently eyeing a potential acquisition of the CRO PPD for around $8bn.

  • Deal Watch May 2016 Deal Watch May 2016

    Doing the complete opposite and consolidating, Quintiles and IMS Health announced the merger of their respective businesses to form a mega-CRO with a combined market capitalisation of $17.6bn.

  • The hidden costs of poor translation The hidden costs of poor translation

    Many CRO project managers complain that their current translation supplier gives them low quality translations and poor service. ... as stand-alone translations rather than translation tables, meaning that the CRO project managers (PMs) have to align

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Barry’s substantial experience of drug discovery deal-making will be of great value to Metrion as we continue to build our worldwide CRO and collaboration business, and Andy’s dedication

  • Lynn Lewis joins Envigo Lynn Lewis joins Envigo

    Lynn Lewis joins Envigo. She becomes the CRO’s senior vice president of global sales.

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis. ... His career has seen him work for Mapi Group, where he held the role of senior director in global

  • Dr Martine Dehlinger-Kremer becomes EUCROF president Dr Martine Dehlinger-Kremer becomes EUCROF president

    Dr Dehlinger-Kremer has over 30 years of clinical research industry experience and currently serves as vice president for global medical and regulatory affairs at San Diego, US-based CRO SynteractHCR.

  • Metrion Biosciences expands operations team Metrion Biosciences expands operations team

    Dr Marc Rogers, chief scientific officer at Metrion Biosciences, said: “ Since becoming an independent CRO in 2015 Metrion has grown rapidly. “

More from appointments
Approximately 12 fully matching, plus 53 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 47 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics